Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Names Distributors for Russia, Kazakhstan, Belarus, Poland

NEW YORK (GenomeWeb) – GenDx today announced distribution deals for its HLA-typing and chimerism monitoring products covering Russia, Kazakhstan, Belarus, and Poland. 

BioChemMack will distribute GenDx's products in Russia, Kazakhstan, and Belarus, while Polgen will be the Netherlands-based firm's distributor in Poland. Products covered by the deals include GenDx's SBTexcellerator for Sanger sequencing-based HLA-typing and its NGSgo next-generation sequencing-based technology, as well as the NGSengine software package. 

"We believe that with the appointment of these two HLA-specialized distributors we are now able to support our customers in Russia, Kazakhstan, Belarus, and Poland with the best tools, services, and education, enabling excellent HLA typing and thereby facilitating better matching and outcome of transplantations," GenDx Managing Director Wietse Mulder said in a statement.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.